Hildred
New York City, New Yorkhildred.com
Overview
Hildred is a New York City-based private equity investment firm focused on control-oriented investments in lower middle-market companies across the healthcare industry. The firm's investment focus includes commercial stage pharmaceutical and OTC products, care delivery services, medical devices, life science tools and diagnostics, outsourced pharmaceutical and clinical services, and healthcare IT. Hildred partners with management teams to drive strategic growth and create value.
Portfolio Companies
6
Website
hildred.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OrangeTwist | Dec 2025 | Strategic | Co-investor |
| Tebra | Dec 2025 | Private Equity | Lead |
| binx health | Apr 2024 | Series F | Lead |
| Hyland's Naturals | Mar 2024 | Private Equity | Co-investor |
| HealthCare.com | Dec 2021 | Series C | Lead |
Key People
Adrianne Shapira
Private Equity Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
